130 related articles for article (PubMed ID: 35633142)
1. A multicentre study of the risk factors associated with recurrence of central serous chorioretinopathy.
Zhou X; Komuku Y; Araki T; Hozumi K; Terasaki H; Miki A; Kuwayama S; Niki M; Matsubara H; Kinoshita T; Nishi T; Gomi F
Acta Ophthalmol; 2022 Dec; 100(8):e1729-e1736. PubMed ID: 35633142
[TBL] [Abstract][Full Text] [Related]
2. RISK FACTORS FOR RECURRENCES OF CENTRAL SEROUS CHORIORETINOPATHY.
Matet A; Daruich A; Zola M; Behar-Cohen F
Retina; 2018 Jul; 38(7):1403-1414. PubMed ID: 28570485
[TBL] [Abstract][Full Text] [Related]
3. Patient characteristics and risk factors for central serous chorioretinopathy: an analysis of 811 patients.
Ersoz MG; Arf S; Hocaoglu M; Sayman Muslubas I; Karacorlu M
Br J Ophthalmol; 2019 Jun; 103(6):725-729. PubMed ID: 30002072
[TBL] [Abstract][Full Text] [Related]
4. Multimodal Imaging in Fibrinous Central Serous Chorioretinopathy Compared with Exudative Maculopathy.
Lyu Y; Li X; Gong Y
Ophthalmologica; 2020; 243(5):360-369. PubMed ID: 32008002
[TBL] [Abstract][Full Text] [Related]
5. Clinical evaluation of neovascular and non-neovascular chronic central serous chorioretinopathy (CSC) diagnosed by swept source optical coherence tomography angiography (SS OCTA).
Sulzbacher F; Schütze C; Burgmüller M; Vécsei-Marlovits PV; Weingessel B
Graefes Arch Clin Exp Ophthalmol; 2019 Aug; 257(8):1581-1590. PubMed ID: 31037488
[TBL] [Abstract][Full Text] [Related]
6. Assessment of macular choroidal thickness by optical coherence tomography and angiographic changes in central serous chorioretinopathy.
Jirarattanasopa P; Ooto S; Tsujikawa A; Yamashiro K; Hangai M; Hirata M; Matsumoto A; Yoshimura N
Ophthalmology; 2012 Aug; 119(8):1666-78. PubMed ID: 22521082
[TBL] [Abstract][Full Text] [Related]
7. CHOROIDAL THICKNESS OF CENTRAL SEROUS CHORIORETINOPATHY SECONDARY TO CORTICOSTEROID USE.
Honda S; Miki A; Kusuhara S; Imai H; Nakamura M
Retina; 2017 Aug; 37(8):1562-1567. PubMed ID: 27787451
[TBL] [Abstract][Full Text] [Related]
8. TWELVE-MONTH EFFICACY OF INTRAVITREAL BEVACIZUMAB INJECTION FOR CHRONIC, ATYPICAL, OR RECURRENT CENTRAL SEROUS CHORIORETINOPATHY.
Chung YR; Kim JW; Song JH; Park A; Kim MH
Retina; 2019 Jan; 39(1):134-142. PubMed ID: 29077604
[TBL] [Abstract][Full Text] [Related]
9. Risk factors and characteristics of central serous chorioretinopathy with later development of macular neovascularisation detected on OCT angiography: a retrospective multicentre observational study.
Zhou X; Komuku Y; Araki T; Terasaki H; Miki A; Kuwayama S; Nishi T; Kinoshita T; Gomi F
BMJ Open Ophthalmol; 2022 Apr; 7(1):. PubMed ID: 35537029
[TBL] [Abstract][Full Text] [Related]
10. Biometric characteristics of eyes with central serous chorioretinopathy.
Oh JH; Oh J; Togloom A; Kim SW; Huh K
Invest Ophthalmol Vis Sci; 2014 Mar; 55(3):1502-8. PubMed ID: 24550360
[TBL] [Abstract][Full Text] [Related]
11. Choroidal thickness measurement by enhanced depth imaging and swept-source optical coherence tomography in central serous chorioretinopathy.
Hamzah F; Shinojima A; Mori R; Yuzawa M
BMC Ophthalmol; 2014 Nov; 14():145. PubMed ID: 25421855
[TBL] [Abstract][Full Text] [Related]
12. SUBFOVEAL CHOROIDAL THICKNESS AND VASCULAR DIAMETER IN ACTIVE AND RESOLVED CENTRAL SEROUS CHORIORETINOPATHY.
Chung YR; Kim JW; Choi SY; Park SW; Kim JH; Lee K
Retina; 2018 Jan; 38(1):102-107. PubMed ID: 28106708
[TBL] [Abstract][Full Text] [Related]
13. Optical Coherence Tomography Angiography Compared with Multimodal Imaging for Diagnosing Neovascular Central Serous Chorioretinopathy.
Ng DS; Ho M; Chen LJ; Yip FL; Teh WM; Zhou L; Mohamed S; Tsang CW; Brelén ME; Chen H; Pang CP; Lai TYY
Am J Ophthalmol; 2021 Dec; 232():70-82. PubMed ID: 34116008
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of choroidal hyperreflective dots in acute and chronic central serous chorioretinopathy.
Hanumunthadu D; Matet A; Rasheed MA; Goud A; Vuppurabina KK; Chhablani J
Indian J Ophthalmol; 2019 Nov; 67(11):1850-1854. PubMed ID: 31638047
[TBL] [Abstract][Full Text] [Related]
15. Morphologic features of large choroidal vessel layer: age-related macular degeneration, polypoidal choroidal vasculopathy, and central serous chorioretinopathy.
Baek J; Lee JH; Jung BJ; Kook L; Lee WK
Graefes Arch Clin Exp Ophthalmol; 2018 Dec; 256(12):2309-2317. PubMed ID: 30259090
[TBL] [Abstract][Full Text] [Related]
16. Subfoveal choroidal thickness in fellow eyes of patients with central serous chorioretinopathy.
Maruko I; Iida T; Sugano Y; Ojima A; Sekiryu T
Retina; 2011 Sep; 31(8):1603-8. PubMed ID: 21487334
[TBL] [Abstract][Full Text] [Related]
17. ACUTE CENTRAL SEROUS CHORIORETINOPATHY: Factors Influencing Episode Duration.
Daruich A; Matet A; Marchionno L; De Azevedo JD; Ambresin A; Mantel I; Behar-Cohen F
Retina; 2017 Oct; 37(10):1905-1915. PubMed ID: 28067724
[TBL] [Abstract][Full Text] [Related]
18. CLINICAL FEATURES OF FLAT IRREGULAR PIGMENT EPITHELIAL DETACHMENT ASSOCIATED WITH CHOROIDAL NEOVASCULARIZATION IN CHRONIC CENTRAL SEROUS CHORIORETINOPATHY.
Guo J; Tang W; Liu W; Chang Q; Xu G
Retina; 2021 Jan; 41(1):199-207. PubMed ID: 32251241
[TBL] [Abstract][Full Text] [Related]
19. Clinical characteristics of central serous chorioretinopathy in patients by age.
Tanaka C; Iwahashi C; Komuku Y; Hozumi K; Mitarai K; Gomi F
Jpn J Ophthalmol; 2021 Nov; 65(6):761-768. PubMed ID: 34387787
[TBL] [Abstract][Full Text] [Related]
20. Central serous chorioretinopathy with and without steroids: A multicenter survey.
Araki T; Ishikawa H; Iwahashi C; Niki M; Mitamura Y; Sugimoto M; Kondo M; Kinoshita T; Nishi T; Ueda T; Kato A; Yasukawa T; Takamura Y; Gomi F
PLoS One; 2019; 14(2):e0213110. PubMed ID: 30818363
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
